Management of immune thrombocytopenic purpura: A prospective study of 147 children from the regional network RHémaP;Purpura thrombocytopénique auto-immun : à propos d'une cohorte prospective de 147 enfants pris en charge dans le réseau d'hématologie pédiatrique des régions PACA et Corse (RHémaP)

Archives de Pediatrie

Volumn 15, Issue 9, 2008, Pages 1398-1406

  Le Meignen, M ^a   Mossler, P ^a   Mates, M ^a   Mathey, C ^b   Hass, A ^c   Monpoux, F ^d   Faverge, B ^c   Fortier, G ^e   Nguyen, J ^c   Belahbib, L ^f   Coache, C ^c   Chamoulli, J M ^f   Moulene E ^g   Sirvent, N ^d   Michel, G ^a   Chambost, H ^a  

^a TIMONE HOSPITAL   (France)

^b CENTRE HOSPITALIER DU PAYS D AIX   (France)

^c Service de pediatrie   (France)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^e CENTRE HOSPITALIER D AVIGNON   (France)

^f Centre Hospitalier Intercommunal Toulon La Seyne sur Mer   (France)

^g Hôpital de Salon de Provence   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; PREDNISOLONE; PREDNISONE;

ARTICLE; BLEEDING; BONE MARROW BIOPSY; BRAIN HEMORRHAGE; CAUSE OF DEATH; CHILD; CHRONIC DISEASE; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEMATOLOGIC DISEASE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PROSPECTIVE STUDY; SYMPTOM; THROMBOCYTE COUNT; TREATMENT INDICATION; TREATMENT RESPONSE;

CHILD; CHILD, PRESCHOOL; FEMALE; FRANCE; GUIDELINE ADHERENCE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MALE; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 51249090110     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2008.06.007     Document Type: Article

References (27)

1. Cines D.B., and Blanchette V.S. Immune thrombocytopenic purpura. N Engl J Med 346 (2002) 995-1008
2. Bolton-Maggs P.H., and Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet 350 (1997) 620-623
3. Bolton-Maggs P.H. Idiopathic thrombocytopenic purpura. Arch Dis Child 83 (2000) 220-222
4. Blanchette V., and Carcao M. Approach to the investigation and management of immune thrombocytopenic purpura in children. Semin Hematol 37 (2000) 299-314
5. Lilleyman J.S. Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology. Arch Dis Child 71 (1994) 251-253
6. Woerner S.J., Abildgaard C.F., and French B.N. Intracranial hemorrhage in children with idiopathic thrombocytopenic purpura. Pediatrics 67 (1981) 453-460
7. Sartorius J.A. Steroid treatment of idiopathic thrombocytopenic purpura in children. Preliminary results of a randomized cooperative study. Am J Pediatr Hematol Oncol 6 (1984) 165-169
8. Imbach P., Barandun S., d'Apuzzo V., et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1 (1981) 1228-1231
9. Blanchette V.S., and Turner C. Treatment of acute idiopathic thrombocytopenic purpura. J Pediatr 108 (1986) 326-327
10. Tarantino M.D., Madden R.M., Fennewald D.L., et al. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin. J Pediatr 134 (1999) 21-26
11. George J.N., Woolf S.H., Raskob G.E., et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 88 (1996) 3-40
12. Vesely S.K., Buchanan G.R., Adix L., et al. Self-reported management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol 25 (2003) 130-133
13. Eden O.B., and Lilleyman J.S. Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group. Arch Dis Child 67 (1992) 1056-1058
14. Lutz P., Villega F., Ducassou S., et al. La prise en charge du purpura thrombocytopénique idiopathique en phase initiale : enquête auprès des membres de la Société Française d'Hématologie Pédiatrique (SHIP). Arch Pediatr 14 (2007) 444-449
15. Rosthøj S., Hedlund-Treutiger I., Rajantie J., et al. Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: A prospective Nordic study of an unselected cohort. J Pediatr 143 (2003) 302-307
16. Buchanan G.R., and Adix L. Grading of hemorrhage in children with idiopathic thrombocytopenic purpura. J Pediatr 141 (2002) 683-688
17. Dubansky A.S., Boyett J.M., Falletta J., et al. Isolated thrombocytopenia in children with acute lymphoblastic leukemia: a rare event in a Pediatric Oncology Group Study. Pediatrics 84 (1989) 1068-1071
18. Kühne T., Imbach P., Bolton-Maggs P.H.B., et al. for the Intercontinental Childhood ITP Study Group. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet 358 (2001) 2122-2125
19. Kühne T., Buchanan G.R., Zimmerman S., et al. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. J Pediatr 143 (2003) 605-608
20. Calpin C., Dick P., Poon A., et al. Is bone marrow aspiration needed in acute childhood idiopathic thrombocytopenic purpura to rule out leukemia?. Arch Pediatr Adolesc Med 152 (1998) 345-347
21. Blanchette V.S., Luke B., Andrew M., et al. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr 123 (1993) 989-995
22. Imbach P., Wagner H.P., Berchtold W., et al. Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet 2 (1985) 464-468
23. Blanchette V., Imbach P., Andrew M., et al. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 344 (1994) 703-707
24. Beck C.E., Nathan P.C., Parkin P.C., et al. Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: a systematic review and meta-analysis of randomized controlled trials. J Pediatr 147 (2005) 521-527
25. Bolton-Maggs P., Tarantino M.D., Buchanan G.R., et al. The child with immune thrombocytopenic purpura: is pharmacotherapy or watchful waiting the best initial management? A panel discussion from the 2002 meeting of the American Society of Pediatric Hematology/Oncology. J Pediatr Hematol Oncol 26 (2004) 146-151
26. Ballow M. Intravenous immunoglobulins: clinical experience and viral safety. J Am Pharm Assoc 42 (2002) 449-458
27. Flan B., and Arrabal S. Manufacture of plasma-derived products in France and measures to prevent the risk of vCJD transmission: precautionary measures and efficacy of manufacturing processes in prion removal. Transfus Clin Biol 14 (2007) 51-62